Pharmaceutical Technology
August 02, 2013
Cover Story
37
8
The pharmaceutical majors target biologics and emerging markets in their manufacturing expansion activities and plans.
August 02, 2013
API Synthesis & Manufacturing
37
8
Stapled peptides offer promise to enable cell permeability, binding to therapeutic targets, and modulation of biological pathways.
August 02, 2013
Solutions in Pharmaceutics
37
8
Extensive comparability testing is required to ensure that biosimilars have comparable profiles to their reference products.
August 02, 2013
BioForum
37
8
The US Supreme Court's Myriad decision satisfied both patient groups and patent holders
August 02, 2013
Outsourcing Outlook
37
8
Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.
August 02, 2013
Ask the Expert
37
8
Siegfried Schmitt of PAREXEL explains how regulatory agencies are getting serious about inspections.
August 02, 2013
Regulation & Compliance
37
8
Nanomedicines have been authorized by European licensing agencies for more than 30 years but are still posing regulatory difficulties.
August 02, 2013
Global Feature
37
8
Industry players brace themselves to face challenges as India's new drug-pricing policy kicks in full gear.
August 02, 2013
Peer-Reviewed Research
37
8
The authors examine alternative solvents for extractables and leachables screening evaluation of process components that provide extraction equivalence and do not interfere chromatographically.
August 02, 2013
In the Spotlight
37
8
Editor's Pick's of Pharmaceutical Science & Technology Innovations: The latest in analytical instrumentation including mass spectrometers, calorimeters, and viscometers.
August 02, 2013
Regulation & Compliance
37
8
Appropriate use of medications promises to improve patient care and curb spending, prompting pharmacists, public health authorities, and manufacturers to promote multiple adherence strategies.
August 02, 2013
Troubleshooting
37
8
The author describes how liquid chromatography-mass spectrometry works and explains some of its advantages and disadvantages, particularly compared to high-performance liquid chromatography.
August 02, 2013
Global Feature
37
8
The bio-pharmaceutical business outlook in South Korea remains positive.
August 02, 2013
Regulation & Compliance
37
8
FDA funds research to further development of innovative generics, while working to address review and approval issues.
August 02, 2013
From The Editor
37
8
As the Supreme Court ruled on generic-drug liability, FDA outlined new rules for warning labels.
August 02, 2013
Issue PDF
37
8
Click the title above to open the Pharmaceutical Technology August 2013 issue in an interactive PDF format.